Follow-up

Monitor RPR until seronegative or stable low titre (e.g. ≤ 1:4 dilutions)

At 1, 3, 6, and 12 months
(pregnant patients should be monitored monthly if high risk of re-infection, and fetal ultrasound if diagnosed at ≥ 10 weeks gestation)

HIV infected patients (any stage):
At 1, 3, 6, 12, and 24 months, then yearly thereafter